These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. [Ramipril can do more. Halting progression of atherosclerosis]. MMW Fortschr Med; 2001 Sep; 143(35-36):45. PubMed ID: 11584530 [No Abstract] [Full Text] [Related]
63. [Ramipril effects on 24 hour profile of blood pressure in patients with mild and moderate hypertension]. Kukushkin SK; Lebedev AV; Manoshkina EM; Shamarin VM Ter Arkh; 1998; 70(9):69-71. PubMed ID: 9821232 [TBL] [Abstract][Full Text] [Related]
64. Effect of ramipril on the incidence of diabetes. Epstein BJ; Cooper-DeHoff RM N Engl J Med; 2007 Feb; 356(5):523; author reply 523-4. PubMed ID: 17269176 [No Abstract] [Full Text] [Related]
65. Ramipril use in Canada: HOPE or HYPE? Pilote L CMAJ; 2003 Mar; 168(5):568-9. PubMed ID: 12615751 [No Abstract] [Full Text] [Related]
66. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Mohler ER; Hiatt WR; Creager MA Circulation; 2003 Sep; 108(12):1481-6. PubMed ID: 12952839 [TBL] [Abstract][Full Text] [Related]
67. Effect of ramipril on cardiovascular events in high-risk patients. Weinsaft JW N Engl J Med; 2000 Jul; 343(1):64; author reply 66. PubMed ID: 10896543 [No Abstract] [Full Text] [Related]
68. Effect of ramipril on the incidence of diabetes. Bangalore S; Messerli FH N Engl J Med; 2007 Feb; 356(5):522; author reply 523-4. PubMed ID: 17267916 [No Abstract] [Full Text] [Related]
69. [New breakthrough for ACE inhibitors. HOPE Study: hope for all vascular patients?]. MMW Fortschr Med; 1999 Oct; 141(42):66-7. PubMed ID: 10912112 [No Abstract] [Full Text] [Related]
70. Walking Intensity Preference of Patients With Peripheral Arterial Disease. de Oliveira MD; Kanegusuku H; de Faria DRG; Wolosker N; Correia MA; Ritti-Dias RM J Cardiopulm Rehabil Prev; 2024 Jan; 44(1):71-72. PubMed ID: 37646619 [No Abstract] [Full Text] [Related]
71. Understanding the role of antioxidant therapy for intermittent claudication; good, bad, or both? Miller SJ; Unthank JL Am J Physiol Heart Circ Physiol; 2015 Sep; 309(5):H734-6. PubMed ID: 26163447 [No Abstract] [Full Text] [Related]
72. Opportunities to explore the physiology of arterial insufficiency and claudication. Curci JA J Vasc Surg; 2020 Mar; 71(3):958. PubMed ID: 32089212 [No Abstract] [Full Text] [Related]
73. Notice of Retraction: Ahimastos AA, et al. Effect of Ramipril on Walking Times and Quality of Life Among Patients With Peripheral Artery Disease and Intermittent Claudication: A Randomized Controlled Trial. JAMA. 2013;309(5):453-460. JAMA; 2015 Oct; 314(14):1520-1. PubMed ID: 26367349 [No Abstract] [Full Text] [Related]